Why this exists

Why melanocortins

One ancient gene keeps the whole body in balance — its colour, its hunger, its answer to stress, the way it heals. This page is the reason melanocortin.com exists: to map that system with equal parts wonder and rigour.

By melanocortin.com editorialLast updated 2026

Long before there were drugs, there was the signal. A single ancient gene — pro-opiomelanocortin, or POMC — is cut, tissue by tissue, into a family of short peptides the body uses to keep itself in balance: to set the colour that shields skin from light, to answer a hard day with cortisol, to sayenough at the end of a meal, to let an inflamed tissue stand down and heal. Five receptors read that signal; two natural brakes oppose it; and from that small, economical toolkit comes a startling share of human physiology.[1]

For most of a century this was biology's most elegant footnote — admired, mapped, and undruggable. Then, in the span of a few years, it became one of medicine's most productive frontiers. melanocortin.com exists to hold both of those truths at once: the wonder of a system the body already uses to protect and repair itself, and the discipline of saying only what the evidence will bear.

The visible tip

Pigmentation is the part of this system you can see, and it is the smallest part of what the system does. On the surface of every pigment cell sits MC1R, a switch with two settings. Turned up — by α-MSH, the system's own messenger — it lays down eumelanin, the brown-black pigment that absorbs ultraviolet light and shields the DNA beneath it. Left quiet, the same cell defaults to pheomelanin, a red-gold pigment that is a poor sunscreen and, under UV, can generate the very damage melanin is meant to prevent.[2] The tan you build in the sun is not decoration; it is this switch doing its job — the melanocortin system reading the light and answering with protection.[1]

The melanocortin pigment switchα-MSH activates the MC1R receptor, switching melanocytes from pale UV-vulnerable pheomelanin to dark protective eumelanin — darkening a lizard and tanning human skin so eumelanin absorbs UV before it damages DNA.α-MSHMC1Rmelanocyteeumelaninthe protective pigmentThe demonstrationThe translationmelanophores disperse pigment — dark in minutesUVeumelanin absorbs UV — shields DNApheomelanin · fair, UV-vulnerableeumelanin · tanned, UV-protective
One molecule, one switch. α-MSH activates MC1R, flipping melanocytes from pale pheomelanin to dark eumelanin — the signal that darkens a lizard in minutes is the same one that tans human skin, where eumelanin then absorbs UV before it reaches DNA.

For some people, the switch is quiet from birth. The common "red-hair" variants of MC1R never traffic properly to the cell surface, so even when the messenger arrives, less of the signal gets through.[3] The visible result is fair skin, freckles, hair that runs to red or gold — and skin that burns where others tan. The invisible result is a lifetime of greater exposure to what sunlight does to unshielded DNA.[2] It is, in the most literal sense, a difference written into one receptor.

What it asks of you

To live with that switch turned low is to learn a discipline early — the routine most people never think about and those who burn can never quite forget: sun protection made a habit, shade found on instinct, the quiet arithmetic of what a bright day will cost. Carried grudgingly, it curdles into self-consciousness. Carried with understanding — knowing exactly which cell, which receptor, which pigment is at stake — it becomes something closer to stewardship of your own skin. Knowing the mechanism doesn't lift the burden, but it changes the mindset you carry it with; and a burden you understand is one you can keep carrying, consistently, for a lifetime. Helping with that understanding is part of why this site exists.

Medicine learned to answer

Here is what turns wonder into more than a feeling: the switch can be spoken to. Afamelanotide is a sturdier copy of the body's own α-MSH — an MC1R agonist that drives protective eumelanin directly, without waiting for the sunlight that, for some people, only causes harm.[4] In 2019 it became the first treatment ever approved for erythropoietic protoporphyria, a disorder in which light is not an inconvenience but agony; people who had organised their whole lives around avoiding the sun gained real, measured hours of tolerance.[5] It is a small, exact proof of something larger — that a signal the body has always used to protect itself can be restored on purpose, and that the melanocortin pigment switch is genuinely druggable, even genuinely kind. See the full entries on afamelanotide and MC1R, the pigment switch.

That is also where we are careful. The line between a medicine that restores protection for a painful disease and a peptide sold online to tan on demand is a real one, and we draw it in the open — risks and all — on the afamelanotide and melanotan pages. Reverence for the biology is not the same as a recommendation, and we never let the first quietly become the second.

The two truths

So we hold two truths on every page. We revere the biology — a system this old, this economical, this quietly central to being alive earns awe. And we cite the claims — because awe without rigour is just marketing, and the reader deserves better than to be sold to. Where the science is settled, we say so plainly. Where it is unsettled, we call it the frontier, not a sure thing. The wonder is real, and it is earned page by page. New here? Start with the melanocortin system — the whole map in one page — or read how we work in the editorial standards.

Education, not a protocol

This page explains why the melanocortin system matters and how it works. It is not medical advice, and it is never a protocol — it gives no dosing, sourcing, or usage instructions for any drug, approved or otherwise. For the science and the documented risks in full, see afamelanotide, melanotan, and the editorial standards.

References

  1. 1.Cone RD. Studies on the physiological functions of the melanocortin system. Endocr Rev. 27(7):736–49. 2006. link ↗
  2. 2.Nasti TH, Timares L. MC1R, eumelanin and pheomelanin: their role in determining the susceptibility to skin cancer. Photochem Photobiol. 91(1):188–200. 2015. link ↗
  3. 3.Beaumont KA, et al. Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk. Hum Mol Genet. 14(15):2145–54. 2005. link ↗
  4. 4.US FDA. SCENESSE (afamelanotide) implant, for subcutaneous use — prescribing information. FDA label (NDA 210797) — mechanism, indication, and dosing. 2019. link ↗
  5. 5.Drugs.com. Scenesse (afamelanotide) FDA approval history. Summary of the 8 October 2019 approval for erythropoietic protoporphyria. 2019. link ↗